Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
Linda Brokāne, Pēteris Alberts(Maxygen (United States)), Agnija Rasa, Inta Jaunalksne, Evija Olmane(Pauls Stradiņš Clinical University Hospital), Donatas Petroška(Vilnius University), Andra Tilgase
Cited by 2
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179